HPV E6/E7 RNA In Situ hybridization signal patterns as biomarkers of three-tier cervical intraepithelial neoplasia grade

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Evans, Mark F ^a   Peng, Zhihua ^a   Clark, Kelli M ^a,b   Adamson, Christine S C ^a   Xiao Jun, Ma ^c   Wu, Xingyong ^c   Wang, Hongwei ^c   Luo, Yuling ^c   Cooper, Kumarasen ^a,b,d  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b FLETCHER ALLEN HEALTH CARE   (United States)

^c Advanced Cell Diagnostics Inc   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; MESSENGER RNA; PROTEIN P16; TUMOR MARKER; VIRUS DNA; BIOLOGICAL MARKER; DNA BINDING PROTEIN; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18; E7 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18; ONCOPROTEIN; VIRUS RNA;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADOLESCENT; ADULT; ARTICLE; CANCER GRADING; CHROMOGENIC IN SITU HYBRIDIZATION; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HIGH RISK PATIENT; HPV E6 GENE; HPV E7 GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; ONCOGENE; P16 GENE; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; RNA ANALYSIS; SIGNAL TRANSDUCTION; UTERINE CERVIX TUMOR; VIRUS DETECTION; CERVICAL INTRAEPITHELIAL NEOPLASIA; CLASSIFICATION; COHORT ANALYSIS; DISEASE COURSE; GENETICS; METABOLISM; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; VIROLOGY; VIRUS GENE; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMARKERS; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE PROGRESSION; DNA-BINDING PROTEINS; FEMALE; GENES, VIRAL; GENOTYPE; HUMANS; IN SITU HYBRIDIZATION; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RNA, VIRAL; YOUNG ADULT;

EID: 84898725019     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091142     Document Type: Article

References (37)

1. Syrjanen KJ (2009) Histology, classification and natural history of cervical intraepithelial neoplasia (CIN). CME J Gynecol Oncol 14: 4-21.
2. Crum C. CIN II exists. United States and Canadian Academy of Pathology (USCAP) 2011 Annual Meeting. Specialty Conference Handout http://www.uscap.org/ index.htm?educmaster.htm: Gynecologic Pathology.
3. Crum CP (2008) Laboratory management of CIN 2: The consensus is consensus. Am J Clin Pathol 130: 162-4.
4. Stoler MH. CIN2 does not exist. United States and Canadian Academy of Pathology (USCAP) 2011 Annual Meeting. Specialty Conference Handout http://www.uscap.org/index.htm?educmaster.htm: Gynecologic Pathology.
5. Waxman AG, Chelmow D, Darragh TM, Lawson H, Moscicki AB (2012) Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix. Obstet Gynecol 120: 1465-71.
6. Darragh TM, Colgan TJ, Thomas Cox J, Heller DS, Henry MR, et al. (2013) For Members of the LAST Project Work Groups. The Lower Anogenital Squamous Terminology Standardization Project for HPV-associated Lesions: Background and Consensus Recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Int J Gynecol Pathol 32: 76-115.
7. Sadler L, Saftlas A, Wang W, Exeter M, Whittaker J, et al. (2004). Treatment for cervical intraepithelial neoplasia and risk of preterm delivery. JAMA 291: 2100-6. (Pubitemid 38580153)
8. Noehr B, Jensen A, Frederiksen K, Tabor A, Kjaer SK (2009) Depth of cervical cone removed by loop electrosurgical excision procedure and subsequent risk of spontaneous preterm delivery. Obstet Gynecol 114: 1232-8.
9. Zeng SY, Liang MR, Li LY, Wu YY (2012) Comparison of the efficacy and complications of different surgical methods for cervical intraepithelial neoplasia. Eur J Gynaecol Oncol 33: 257-60.
10. Wang F, Flanagan J, Su N, Wang LC, Bui S, et al. (2012) RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J Mol Diagn 14: 22-9.
11. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55: 244-65. (Pubitemid 34293391)
12. Doorbar J (2006) Molecular biology of human papillomavirus infection and cervical cancer Clin Sci (Lond). 110: 525-41.
13. Doorbar J (2007) Papillomavirus life cycle organization and biomarker selection. Dis Markers 23: 297-313.
14. Doorbar J, Quint W, Banks L, Bravo IG, Stoler M, et al (2012) The biology and life-cycle of human papillomaviruses. Vaccine 30 Suppl 5: F55-70.
15. Doeberitz Mv, Vinokurova S (2009) Host factors in HPV-related carcinogenesis: cellular mechanisms controlling HPV infections. Arch Med Res. 40: 435-42.
16. INK4a to highlight transforming HPV infections. Expert Rev Proteomics. 9: 149-63.
17. Chaiwongkot A, Vinokurova S, Pientong C, Ekalaksananan T, Kongyingyoes B, et al (2013) Differential methylation of E2 binding sites in episomal and integrated HPV 16 genomes in preinvasive and invasive cervical lesions. Int J Cancer 132: 2087-94.
18. Solomon D, Schiffman M, Tarone R, ALTS Study group (2001) Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 93: 293-9. (Pubitemid 32219816)
19. Evans MF, Mount SL, Vacek PM, Cooper K (2003) High-risk human papillomavirus type does not predict grade of cervical intraepithelial neoplasia. Eur J Gynaecol Oncol 24: 373-6. (Pubitemid 37236557)
20. Evans MF, Adamson CS, Simmons-Arnold L, Cooper K (2005) Touchdown General Primer (GP5+/GP6+) PCR and optimized sample DNA concentration support the sensitive detection of human papillomavirus. BMC Clin Pathol 16;5: 10.
21. de Roda Husman AM, Snijders PJ, Stel HV, van den Brule AJ, Meijer CJ, et al (1995) Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. Br J Cancer 72: 412-7.
22. Evans MF, Mount SL, Beatty BG, Cooper K (2002) Biotinyl-tyramide-based in situ hybridization signal patterns distinguish human papillomavirus type and grade of cervical intraepithelial neoplasia. Mod Pathol 15: 1339-47. (Pubitemid 35463003)
23. Cooper K, Herrington CS, Graham AK, Evans MF, McGee JO (1991) In situ human papillomavirus (HPV) genotyping of cervical intraepithelial neoplasia in South African and British patients: evidence for putative HPV integration in vivo. J Clin Pathol 44: 400-5.
24. Stoler MH, Broker TR (1986) In situ hybridization detection of human papillomavirus DNAs and messenger RNAs in genital condylomas and a cervical carcinoma. Hum Pathol 17: 1250-8. (Pubitemid 17023680)
25. Higgins GD, Uzelin DM, Phillips GE, Pieterse AS, Burrell CJ (1991) Differing characteristics of human papillomavirus RNA-positive and RNA-negative anal carcinomas. Cancer 68: 561-7.
26. Higgins GD, Uzelin DM, Phillips GE, Burrell CJ (1991) Presence and distribution of human papillomavirus sense and antisense RNA transcripts in genital cancers. J Gen Virol 72: 885-95.
27. Stoler MH, Rhodes CR, Whitbeck A, Wolinsky SM, Chow LT, et al. (1992) Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum Pathol 23: 117-28.
28. Dürst M, Glitz D, Schneider A, zur Hausen H (1992) Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization. Virology 189: 132-40.
29. Higgins GD, Uzelin DM, Phillips GE, McEvoy P, Marin R, et al. (1992) Transcription patterns of human papillomavirus type 16 in genital intraepithelial neoplasia: evidence for promoter usage within the E7 open reading frame during epithelial differentiation. J Gen Virol. 1992 Aug;73 (Pt 8): 2047-57.
30. Higgins GD, Phillips GE, Smith LA, Uzelin DM, Burrell CJ (1992) High prevalence of human papillomavirus transcripts in all grades of cervical intraepithelial glandular neoplasia. Cancer 70: 136-46.
31. Vormwald-Dogan V, Fischer B, Bludau H, Freese UK, Gissmann L, et al. (1992) Sense and antisense transcripts of human papillomavirus type 16 in cervical cancers. J Gen Virol 73: 1833-8.
32. Galgano MT, Castle PE, Atkins KA, Brix WK, Nassau SR, et al. (2010) Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol 34: 1077-87.
33. Moscicki AB, Ma Y, Wibbelsman C, Darragh TM, Powers A, et al. (2010) Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. Obstet Gynecol 116: 1373-80.
34. McAllum B, Sykes PH, Sadler L, Macnab H, Simcock BJ, et al. (2011) Is the treatment of CIN 2 always necessary in women under 25 years old? Am J Obstet Gynecol 205: 478.e1-7.
35. Syrjänen K, Shabalova I, Sarian L, Naud P, Longatto-Filho A, et al. (2012) Covariates of high-risk human papillomavirus (HPV) infections are distinct for incident CIN1, CIN2 and CIN3 as disclosed by competing-risks regression models. Eur J Gynaecol Oncol 33: 5-14.
36. Fukuchi E, Fetterman B, Poitras N, Kinney W, Lorey T, et al. (2013) Risk of cervical precancer and cancer in women with cervical intraepithelial neoplasia grade 1 on endocervical curettage. J Low Genit Tract Dis 17: 255-60.
37. De Marchi Triglia R, Metze K, Zeferino LC, Lucci De Angelo Andrade LA (2009) HPV in situ hybridization signal patterns as a marker for cervical intraepithelial neoplasia progression. Gynecol Oncol 112: 114-8.